Evomedis launches research collaboration with the University of Graz (Group of Univ.-Prof. Dr. Eva Roblegg)
Joint research to develop innovative formulations for wound healing
Graz, 2025 – Evomedis is pleased to announce a new collaboration with the research group of Univ.-Prof. Dr. Eva Roblegg at the Institute of Pharmaceutical Sciences, University of Graz.
The goal of this collaboration is to develop innovative cell-based formulations that promote fast and sustained healing of severe burn and chronic wounds.
Prof. Roblegg and her team focus on the development of advanced drug delivery systems using state-of-the-art manufacturing technologies. With the help of cell models, they study how such systems can cross and interact with biological barriers.
By combining this scientific excellence with Evomedis’ industrial expertise, the partnership opens new perspectives for effective therapeutic concepts in regenerative medicine.
“This partnership combines the scientific excellence of the University of Graz with the biotechnological development expertise of Evomedis to advance new and effective therapeutic concepts in regenerative medicine,” says Univ.-Prof. Dr. Eva Roblegg.
Through this collaboration, Evomedis further expands its research and development activities in Austria and strengthens the bridge between academic research and biotechnological application.